Of both PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28388412 HIV-1 and HIV-2 infections. J Infect Dis 2010, 201:1150?154. 6. Baroncelli S, Galluzzo CM, Pirillo M, Mancini MG, et al: Microbial translocation is associated with residual viral replication in HAARTtreated HIV+ order UNC0642 subjects with < 50 copies/ml HIV-1 RNA. J Clin Virol 2009, 46:367?70. 7. Ancuta P, Kamat PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28827318 A, Kunstman KJ, Kim E, et al: Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. Plos One 2008, 3:e2516. 8. Epple HJ, Schneider T, Troeger H, Kunkel D, et al: Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009, 58:220?27. 9. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al: Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. Plos Pathogens 2010, 6:e1001052. 10. Jiang W, Lederman MM, Hunt P, Sieg SF, et al: Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009, 199:1177?185. 11. Funderburg N, Andrade A, Chan E, Lu D, Rosenkranz S, et al: Delayed reduction in CD4 T cell turnover following viral control correlates with markers of microbial trnaslocation in treatment-naive patients receiving RAL-based ART: preliminary results from ACTG A5248. Boston: 18th Conference on Retroviruses and Opportunistic Infections; 2011. February 2011, Boston, Session 28, poster 318. 12. Hunt PW, Brenchley J, Sinclair E, McCune JM, et al: Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197:126?33. 13. L ez M, Soriano V, Peris-Pertusa A, Rall N, et al: Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. AIDS Res Hum Retroviruses 2011, 27:157?65. 14. D’Ettorre G, Paiardini M, Zaffiri L, Andreotti M, et al: HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy15.16.17.18.19.20.21.22.23.24.25.26.27.28.correlates with immune activation and increased levels of LPS. Curr HIV Res 2011, 9:148?53. Cassol E, Rossow T, Seebregts C, Cassol S: Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure? J Infect Dis 2011, 203:747?48. Pilakka-Kanthikeel S, Huang S, Fenton T, Borkowsky W, et al: Microbial translocation is increased in HIV-infected children on ART and is independent of viral replication and immune activation. 18th Conference on Retroviruses and Opportunistic Infections 2011, 142:728. Boston, Session. Papasavvas E, Pistilli M, Reynolds G, Bucki R, et al: Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1 infected patients. AIDS 2009, 23:369?75. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R: Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218?23. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al: Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol. 2005, 142:481?89. Ancuta P, Autissier P, Wurcel A, Zaman T, Stone D, Gabuzda D: CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. J Immunol 2006, 176:5760?771. Munsaka SM, Agsalda M, Troelstrup D, H.
